Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · IEX Real-Time Price · USD
36.08
+0.66 (1.86%)
At close: Jul 26, 2024, 4:00 PM
37.54
+1.46 (4.05%)
After-hours: Jul 26, 2024, 7:11 PM EDT
Collegium Pharmaceutical Market Cap
Collegium Pharmaceutical has a market cap or net worth of $1.18 billion as of July 26, 2024. Its market cap has increased by 58.25% in one year.
Market Cap
1.18B
Enterprise Value
1.49B
1-Year Change
58.25%
Ranking
Category
Stock Price
$36.08
Market Cap Chart
Since May 7, 2015, Collegium Pharmaceutical's market cap has increased from $242.20M to $1.18B, an increase of 387.35%. That is a compound annual growth rate of 18.73%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 25, 2024 | 1.16B | 15.44% |
Dec 29, 2023 | 1.00B | 28.87% |
Dec 30, 2022 | 778.90M | 20.63% |
Dec 31, 2021 | 645.70M | -6.79% |
Dec 31, 2020 | 692.70M | 0.39% |
Dec 31, 2019 | 690.00M | 20.86% |
Dec 31, 2018 | 570.90M | -5.02% |
Dec 29, 2017 | 601.10M | 34.93% |
Dec 30, 2016 | 445.50M | -21.69% |
Dec 31, 2015 | 568.90M | 134.89% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Artivion | 1.17B |
AtriCure | 1.16B |
Autolus Therapeutics | 1.14B |
Arcutis Biotherapeutics | 1.13B |
Enliven Therapeutics | 1.13B |
Pulse Biosciences | 1.12B |
Innoviva | 1.10B |
Tyra Biosciences | 1.10B |